granisetron has been researched along with sibutramine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukui, H; Furukawa, H; Iwachido, T; Kitaura, H; Miwa, E | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for granisetron and sibutramine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for granisetron and sibutramine
| Article | Year |
|---|---|
Various emetogens increase the secretion of salivary amylase in rats: a potential model in emesis research.
Topics: Adrenergic beta-Agonists; Amylases; Animals; Apomorphine; Cisplatin; Cyclobutanes; Depression, Chemical; Dioxoles; Dose-Response Relationship, Drug; Emetics; Granisetron; Lithium Chloride; Male; Rats; Rats, Wistar; Rolipram; Saliva; Serotonin Antagonists; Stimulation, Chemical; Vagotomy | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |